[Experimental study on tissue engineered cartilage constructed by three-dimensional bioprinted human adipose-derived stem cells combined with gelatin methacryloyl].
Abstract
[OBJECTIVE] To explore the feasibility of three-dimensional (3D) bioprinted adipose-derived stem cells (ADSCs) combined with gelatin methacryloyl (GelMA) to construct tissue engineered cartilage.
[METHODS] Adipose tissue voluntarily donated by liposuction patients was collected to isolate and culture human ADSCs (hADSCs). The third generation cells were mixed with GelMA hydrogel and photoinitiator to make biological ink. The hADSCs-GelMA composite scaffold was prepared by 3D bioprinting technology, and it was observed in general, and observed by scanning electron microscope after cultured for 1 day and chondrogenic induction culture for 14 days. After cultured for 1, 4, and 7 days, the composite scaffolds were taken for live/dead cell staining to observe cell survival rate; and cell counting kit 8 (CCK-8) method was used to detect cell proliferation. The composite scaffold samples cultured in cartilage induction for 14 days were taken as the experimental group, and the composite scaffolds cultured in complete medium for 14 days were used as the control group. Real-time fluorescent quantitative PCR (qRT-PCR) was performed to detect cartilage formation. The relative expression levels of the mRNA of cartilage matrix gene [(aggrecan, ACAN)], chondrogenic regulatory factor (SOX9), cartilage-specific gene [collagen type Ⅱ A1 (COLⅡA1)], and cartilage hypertrophy marker gene [collagen type ⅩA1 (COLⅩA1)] were detected. The 3D bioprinted hADSCs-GelMA composite scaffold (experimental group) and the blank GelMA hydrogel scaffold without cells (control group) cultured for 14 days of chondrogenesis were implanted into the subcutaneous pockets of the back of nude mice respectively, and the materials were taken after 4 weeks, and gross observation, Safranin O staining, Alcian blue staining, and collagen type Ⅱ immunohistochemical staining were performed to observe the cartilage formation in the composite scaffold.
[RESULTS] Macroscope and scanning electron microscope observations showed that the hADSCs-GelMA composite scaffolds had a stable and regular structure. The cell viability could be maintained at 80%-90% at 1, 4, and 7 days after printing, and the differences between different time points were significant ( <0.05). The results of CCK-8 experiment showed that the cells in the scaffold showed continuous proliferation after printing. After 14 days of chondrogenic induction and culture on the composite scaffold, the expressions of ACAN, SOX9, and COLⅡA1 were significantly up-regulated ( <0.05), the expression of COLⅩA1 was significantly down-regulated ( <0.05). The scaffold was taken out at 4 weeks after implantation. The structure of the scaffold was complete and clear. Histological and immunohistochemical results showed that cartilage matrix and collagen type Ⅱ were deposited, and there was cartilage lacuna formation, which confirmed the formation of cartilage tissue.
[CONCLUSION] The 3D bioprinted hADSCs-GelMA composite scaffold has a stable 3D structure and high cell viability, and can be induced differentiation into cartilage tissue, which can be used to construct tissue engineered cartilage and .
[METHODS] Adipose tissue voluntarily donated by liposuction patients was collected to isolate and culture human ADSCs (hADSCs). The third generation cells were mixed with GelMA hydrogel and photoinitiator to make biological ink. The hADSCs-GelMA composite scaffold was prepared by 3D bioprinting technology, and it was observed in general, and observed by scanning electron microscope after cultured for 1 day and chondrogenic induction culture for 14 days. After cultured for 1, 4, and 7 days, the composite scaffolds were taken for live/dead cell staining to observe cell survival rate; and cell counting kit 8 (CCK-8) method was used to detect cell proliferation. The composite scaffold samples cultured in cartilage induction for 14 days were taken as the experimental group, and the composite scaffolds cultured in complete medium for 14 days were used as the control group. Real-time fluorescent quantitative PCR (qRT-PCR) was performed to detect cartilage formation. The relative expression levels of the mRNA of cartilage matrix gene [(aggrecan, ACAN)], chondrogenic regulatory factor (SOX9), cartilage-specific gene [collagen type Ⅱ A1 (COLⅡA1)], and cartilage hypertrophy marker gene [collagen type ⅩA1 (COLⅩA1)] were detected. The 3D bioprinted hADSCs-GelMA composite scaffold (experimental group) and the blank GelMA hydrogel scaffold without cells (control group) cultured for 14 days of chondrogenesis were implanted into the subcutaneous pockets of the back of nude mice respectively, and the materials were taken after 4 weeks, and gross observation, Safranin O staining, Alcian blue staining, and collagen type Ⅱ immunohistochemical staining were performed to observe the cartilage formation in the composite scaffold.
[RESULTS] Macroscope and scanning electron microscope observations showed that the hADSCs-GelMA composite scaffolds had a stable and regular structure. The cell viability could be maintained at 80%-90% at 1, 4, and 7 days after printing, and the differences between different time points were significant ( <0.05). The results of CCK-8 experiment showed that the cells in the scaffold showed continuous proliferation after printing. After 14 days of chondrogenic induction and culture on the composite scaffold, the expressions of ACAN, SOX9, and COLⅡA1 were significantly up-regulated ( <0.05), the expression of COLⅩA1 was significantly down-regulated ( <0.05). The scaffold was taken out at 4 weeks after implantation. The structure of the scaffold was complete and clear. Histological and immunohistochemical results showed that cartilage matrix and collagen type Ⅱ were deposited, and there was cartilage lacuna formation, which confirmed the formation of cartilage tissue.
[CONCLUSION] The 3D bioprinted hADSCs-GelMA composite scaffold has a stable 3D structure and high cell viability, and can be induced differentiation into cartilage tissue, which can be used to construct tissue engineered cartilage and .
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | liposuction
|
지방흡입 | dict | 1 | |
| 해부 | subcutaneous
|
피하조직 | dict | 1 | |
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | cartilage
|
scispacy | 1 | ||
| 해부 | adipose-derived stem cells
|
scispacy | 1 | ||
| 해부 | ADSCs
→ adipose-derived stem cells
|
scispacy | 1 | ||
| 해부 | Adipose tissue
|
scispacy | 1 | ||
| 해부 | hADSCs
→ human ADSCs
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | live/dead cell
|
scispacy | 1 | ||
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | cartilage matrix
|
scispacy | 1 | ||
| 해부 | back
|
scispacy | 1 | ||
| 해부 | cartilage tissue
|
scispacy | 1 | ||
| 합병증 | subcutaneous pockets
|
scispacy | 1 | ||
| 약물 | ADSCs
→ adipose-derived stem cells
|
scispacy | 1 | ||
| 약물 | CCK-8
→ cell counting kit 8
|
C0007584
Cell Count
|
scispacy | 1 | |
| 약물 | Alcian blue
|
C0001933
Alcian Blue
|
scispacy | 1 | |
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | photoinitiator
|
scispacy | 1 | ||
| 약물 | electron
|
scispacy | 1 | ||
| 약물 | COLⅡA1
→ collagen type Ⅱ A1
|
scispacy | 1 | ||
| 질환 | hypertrophy
|
C0020564
Hypertrophy
|
scispacy | 1 | |
| 질환 | GelMA
→ gelatin methacryloyl
|
scispacy | 1 | ||
| 기타 | human adipose-derived stem cells
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | human ADSCs
|
scispacy | 1 | ||
| 기타 | GelMA
→ gelatin methacryloyl
|
scispacy | 1 | ||
| 기타 | aggrecan
|
scispacy | 1 | ||
| 기타 | ACAN
|
scispacy | 1 | ||
| 기타 | SOX9
|
scispacy | 1 | ||
| 기타 | cartilage-specific
|
scispacy | 1 | ||
| 기타 | collagen
|
scispacy | 1 | ||
| 기타 | nude mice
|
scispacy | 1 | ||
| 기타 | Safranin O
|
scispacy | 1 |
MeSH Terms
Adipose Tissue; Animals; Cartilage; Cell Differentiation; Cells, Cultured; Gelatin; Humans; Mice; Mice, Nude; Stem Cells; Tissue Engineering; Tissue Scaffolds
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.
- Hyperhidrosis: Prevalence, Diagnosis, and Stepwise Treatment.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Venous thromboembolism prophylaxis regimen for patients undergoing deep inferior epigastric perforator flap breast reconstruction.
- Immediate one-stage subcutaneous breast reconstruction without ADM: A single-center 6-year experience.